BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$478M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Alibaba
BABA
|
+$295M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$261M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$995M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$128M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$112M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$109M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.51% |
| 2 | Financials | 5.78% |
| 3 | Consumer Discretionary | 5.73% |
| 4 | Healthcare | 5.19% |
| 5 | Communication Services | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Byline Bancorp
BY
$1.78B
| $57.8K | ﹤0.01% |
3,022
-372
| -11% | -$7.13K |
|
|
LSI
3202
DELISTED
Life Storage, Inc.
LSI
| $57.6K | ﹤0.01% |
909
-18,596
| -95% | -$1.19M |
|
3203
TechTarget
TTGT
$277M
| $57.6K | ﹤0.01% |
2,709
-1,562
| -37% | -$29.2K |
|
|
HOME
3204
DELISTED
At Home Group Inc.
HOME
| $57.5K | ﹤0.01% |
8,639
-1,468
| -15% | -$26K |
|
|
PGNX
3205
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $57.5K | ﹤0.01% |
9,325
-8,231
| -47% | -$39.7K |
|
3206
Cytokinetics
CYTK
$10.2B
| $57.5K | ﹤0.01% |
5,107
-4,464
| -47% | -$43K |
|
3207
York Water
YORW
$536M
| $57.3K | ﹤0.01% |
1,604
-1,083
| -40% | -$37.2K |
|
|
EIDX
3208
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $57.2K | ﹤0.01% |
1,841
-1,569
| -46% | -$42.5K |
|
|
FFWM
3209
DELISTED
First Foundation Inc
FFWM
| $57.2K | ﹤0.01% |
4,254
-3,674
| -46% | -$50.7K |
|
|
NVO
3210
Novo Nordisk
NVO
$205B
| $57K | ﹤0.01% |
2,234
-492
| -18% | -$12.2K |
|
3211
Metallus
MTUS
$892M
| $56.8K | ﹤0.01% |
6,985
-2,148
| -24% | -$19.4K |
|
3212
Schwab US REIT ETF
SCHH
$11.4B
| $56.7K | ﹤0.01% |
2,552
-464
| -15% | -$10.4K |
|
|
OMP
3213
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
| $56.5K | ﹤0.01% |
2,628
+2,623
| +52,460% | +$52.8K |
|
3214
LeMaitre Vascular
LMAT
$1.87B
| $56.4K | ﹤0.01% |
2,017
-1,320
| -40% | -$36.7K |
|
|
ATRS
3215
DELISTED
Antares Pharma, Inc.
ATRS
| $56.3K | ﹤0.01% |
17,104
-12,949
| -43% | -$37.5K |
|
|
GNC
3216
PUT
DELISTED
GNC Holdings, Inc.
GNC
| $56.3K | ﹤0.01% |
375
| – | – |
|
|
LDL
3217
DELISTED
Lydall, Inc.
LDL
| $56.2K | ﹤0.01% |
2,782
-740
| -21% | -$16.1K |
|
3218
1-800-Flowers.com
FLWS
$261M
| $56.1K | ﹤0.01% |
2,969
-2,580
| -46% | -$49.3K |
|
|
STEL
3219
DELISTED
Stellar Bancorp
STEL
| $56.1K | ﹤0.01% |
1,992
-1,722
| -46% | -$51K |
|
3220
CryoPort
CYRX
$766M
| $56K | ﹤0.01% |
3,057
-2,673
| -47% | -$42.4K |
|
3221
Martin Midstream Partners
MMLP
$89.6M
| $56K | ﹤0.01% |
7,840
+7,826
| +55,900% | +$64.5K |
|
3222
CytomX Therapeutics
CTMX
$730M
| $55.7K | ﹤0.01% |
4,968
-4,291
| -46% | -$45K |
|
|
DHIL
3223
DELISTED
Diamond Hill
DHIL
| $55.7K | ﹤0.01% |
393
-289
| -42% | -$41.3K |
|
3224
FRP Holdings
FRPH
$425M
| $55.6K | ﹤0.01% |
1,994
-624
| -24% | -$15.4K |
|
3225
Viking Therapeutics
VKTX
$3.84B
| $55.5K | ﹤0.01% |
6,691
-5,990
| -47% | -$51.2K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2019 Portfolio in Review
As of Q2 2019, BNP Paribas Financial Markets held 4,663 positions worth $50.2B, up 8.5% from $46.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets's Q2 2019 filing shows 353 new, 1,075 increased, 2,687 reduced and 125 closed positions. Its largest new stake was Cigna: 315,599 shares worth $49.7M. The largest sale was Invesco QQQ Trust, an estimated $995M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.6% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2019 buy was Cigna: 315,599 shares worth $49.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $478M increase.
- BNP Paribas Financial Markets's biggest Q2 2019 reduction was Invesco QQQ Trust, cutting an estimated $995M.
- BNP Paribas Financial Markets fully exited ARRIS International plc Ordinary Shares in Q2 2019, selling an estimated $40.4M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $50.2B portfolio in Q2 2019.
- BNP Paribas Financial Markets opened 353 new positions and closed 125 in Q2 2019.
- BNP Paribas Financial Markets's portfolio value rose 8.5% quarter-over-quarter to $50.2B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2019, filed 30 Jul 2019.